In re EpiPen ERISA Litigation (Klein v. Prime Therapeutics, LLC)

**EpiPen Pricing Lawsuit Against Employee Health Plan** This case involved a lawsuit against Prime Therapeutics, a company that administers prescription drug benefits for employer health plans. Employees sued the company over how it handled EpiPen pricing in their workplace health insurance plans. EpiPens are life-saving devices for people with severe allergies, and their prices had increased dramatically. The workers claimed that Prime Therapeutics failed in its legal duty to manage their health plan properly and look out for employees' best interests when dealing with EpiPen costs. They argued the company didn't do enough to control drug prices or find more affordable alternatives for plan members. The specific outcome of this case is not detailed in the available information, so it's unclear how the court ultimately ruled. **What This Means for Workers:** This case highlights an important issue for employees with employer-sponsored health insurance. Companies that manage your health benefits have a legal obligation to act in your best interest, including trying to control prescription drug costs. If you believe your health plan administrator isn't properly managing drug prices or plan benefits, you may have legal rights under federal employee benefit laws.